Stocks and Investing Stocks and Investing
Mon, October 18, 2021
Sun, October 17, 2021
Fri, October 15, 2021
Thu, October 14, 2021
Wed, October 13, 2021
Tue, October 12, 2021

David Lebowitz Maintained (SNDX) at Hold with Increased Target to $21 on, Oct 12th, 2021


Published on 2024-10-27 18:08:05 - WOPRAI, David Lebowitz
  Print publication without navigation


David Lebowitz of Morgan Stanley, Maintained "Syndax Pharmaceuticals, Inc." (SNDX) at Hold with Increased Target from $20 to $21 on, Oct 12th, 2021.

David, nor any peers, have made any analyst calls on SNDX in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30